Reneo Pharmaceuticals Inc., which announced in December the failure of its drug to treat rare genetic diseases, said it will be acquired by OnKure Inc., a Boulder, Colo.-based privately held biopharmaceutical company.
With first drug trial underway, Boulder's OnKure inks merger with Reneo Pharma to go public – Boulder Daily Camera dailycamera.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailycamera.com Daily Mail and Mail on Sunday newspapers.
Reneo Pharmaceuticals and OnKure Announce Proposed Merger marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Reneo Pharmaceuticals gains on deal to merge with OnKure (NASDAQ:RPHM) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
OnKure hitches Reneo's ride to Nasdaq, with $65M PIPE to boot fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.